恆指考驗23,900獲支持曾續升逾200點 科技及友邦與傳統銀行領漲
美國8月貿易逆差擴至14年高兼超預期，加上總統特朗普叫停新一輪抗疫刺激方案磋商直至大選結束後，美股三大指數昨晚全面倒跌1.3%-1.6%。亞太區股市個別發展，但升跌均不足0.9%。
IHS Mark數據顯示，香港9月PMI由前值44，改善至47.7創三個月高。港股連升第三天，恆指今天高開19點報23,999欠承接，曾倒跌75點低見23,905獲支持，再度抽高曾漲206點至24,187，現造24,130，續升150點或0.6%，成交額402億元。
藍籌股普遍反覆向好，匯控(00005.HK)連續第三天反覆向好，今早高低見31.6/31元，現造31.4元，續升1.1%；旗下恆生(00011.HK)曾逼近20天線(117.5元)，高見117.4元，現造117.1元，續升0.8%。中銀(02388.HK)續升1%曾高見21.25元。友邦(01299.HK)逆兩大中資險股突破20天線(78.95)，最高見79.9元，現造79.75元，續升1.1%。
納指昨晚在大型科網股吐逾2%-3%主導倒跌1.6%，但恆生科技指數連升第四天，最高見7,448，現造7,432，續升1.3%。重磅股騰訊(00700.HK)續升1.3%曾反覆高見536元；阿里巴巴-SW(09988.HK)繼昨天稍作整固後，今早股價高見287.6元，創逾一個月高，現造286.8元，回升2.4%；小米-W(01810.HK)續升0.5%曾高見21.65元。蘋果下周二舉行網上年度最大產品發布活動，料推新款5G iPhone，瑞聲(02018.HK)及舜宇(02382.HK)續升1.3%及3.9%，報44.05元及124.2元，後者股價升破20天線。
地產股以新世界(00017.HK)、新地(00016.HK)及長實集團(01113.HK)表現最好，股價依次升1.2%-2%，後者報39.05元。不過，藥明生物(02269.HK)扭五連漲反覆吐逾1%報201元；中信股份(00267.HK)跌1%報5.65元。此外，中資金融股也普遍反覆偏軟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
